Ophthalmology · Spring, TX
NPI
1336150614
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4701 Fm 2920, Suite C-2
Spring, TX, 77388
Phone (713) 817-8141
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,181 services
Medicare patients, 2024
194
Average age 77
Drug cost, 2024
$545K
508 prescriptions
Company payments, 2025
$36.02
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John P Stokes was code 92134 (computerized ophthalmic imaging), 399 times for 180 patients. In total John P Stokes billed 1,181 services in 22 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 399 | 180 | $26.29 | $10K |
| 92201 Ophthalmological E&M | Office | 188 | 134 | $16.60 | $3,121 |
| 92014 Ophthalmological E&M | Office | 188 | 141 | $77.13 | $15K |
| 67028 Intravitreal Injection | Office | 149 | 39 | $72.68 | $11K |
| 92012 Ophthalmological E&M | Office | 103 | 57 | $52.81 | $5,439 |
| J9035 Injection, bevacizumab, 10 mg | Office | 69 | 22 | $53.14 | $3,667 |
| 99213 Office E&M - Established | Office | 18 | 16 | $69.25 | $1,247 |
| 99212 Office E&M - Established | Office | 16 | 12 | $43.06 | $689 |
By year: 2022 $155K for 2,111 services; 2023 $112K for 1,888 services; 2024 $57K for 1,181 services.
Medicare prescription drug claims, 2024
In 2024, the drug John P Stokes prescribed most often to Medicare patients was Eylea (Aflibercept), with 135 prescriptions and refills. In total John P Stokes wrote 508 Medicare prescriptions that cost $545K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 135 | 185 | 31 | $336K |
| Latanoprost Generic | 63 | 95 | 18 | $304 |
| Timolol Maleate Generic | 43 | 104 | 15 | $514 |
| Prednisolone Acetate Generic | 41 | 51 | 18 | $1,375 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 39 | 42 | 21 | $425 |
| Vabysmo Faricimab-Svoa | 23 | 29 | Under 11 | $86K |
| Izervay Avacincaptad Pegol Sodium/Pf | 21 | 21 | Under 11 | $69K |
| Brimonidine Tartrate Generic | 19 | 20 | Under 11 | $220 |
| Combigan Brimonidine Tartrate/Timolol | 13 | 19 | Under 11 | $3,630 |
| Bromfenac Sodium Generic | 12 | 12 | Under 11 | $1,780 |
Brand drugs: 297 claims; generic drugs: 211 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John P Stokes $36.02 ($36.02 in general payments such as food, travel and fees) from 1 company. The largest payer was Regeneron Healthcare Solutions, Inc. with $36.02.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $36.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.